Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
Listen to expert insights from Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, as they discuss new data presented at CROI 2022, including key findings on investigational options for PrEP, interactions between hormone therapy and PrEP in transgender individuals, impact of anticholinergic drug effects on older PWH, and medication adherence in PWH.
Decera Clinical Education Infectious Disease Podcast · Fidelia Bernice PharmD, Jennifer Cocohoba PharmD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:
- Islatravir tissue and plasma distribution after monthly oral dosing
- Pharmacokinetics, safety, and acceptability of a tenofovir vaginal ring
- PrEP and Hormone Therapy in Transgender Individuals
- Anticholinergic drug effects in older PWH
- Adherence in PWH
Presenters:
Fidelia Bernice, PharmD
Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland
Jennifer Cocohoba, PharmD
Professor
Department of Clinical Pharmacy
University of California, San Francisco
San Francisco, California
Link to full program:
https://bit.ly/3tdkXfJ
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.